Metastasis is altered through multiple processes regulated by the E2F1 transcription factor

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• The E2F transcription factor family regulates critical cellular processes including cell cycle, angiogenesis, and metastasis.
• Dysregulation of the Rb/E2F pathway is implicated in various cancers, notably breast cancer.
• Previous studies indicate E2F1 deficiency reduces metastasis in specific breast cancer mouse models.

Purpose of the Study:

• To employ a bioinformatic approach to identify E2F1-regulated genomic alterations driving the metastatic cascade in breast cancer mouse models.
• To investigate the impact of E2F1 ablation on tumor etiology and genomic landscape.

Main Methods:

• Utilized bioinformatic analysis, including gene expression profiling and whole-genome sequencing.
• Compared E2F1 knockout (E2F1-/-) and wild-type (E2F1+/+) mouse models (MMTV-Neu and MMTV-PyMT).
• Performed gene set analysis on mutated genes to identify affected pathways.

Main Results:

• Gene expression analysis showed minimal transcriptome changes in non-metastatic E2F1-/- tumors.
• Whole-genome sequencing revealed significant differences in tumor etiology between E2F1-/- and E2F1+/+ tumors.
• Loss of E2F1 in the Neu model correlated with increased reliance on double-strand break repair.
• No significant difference in SNV mutation burden between E2F1 WT and E2F1 KO mice across models.
• E2F1-/- tumors exhibited mutations in cell adhesion pathway genes.

Conclusions:

• E2F1 plays a complex role in the metastatic process, influencing tumor etiology and genomic alterations.
• The cell adhesion pathway emerges as a potential target for disrupting metastasis in E2F1-deficient tumors.
• Further research is needed to fully elucidate the drivers of metastasis in the context of E2F1 function.